<DOC>
	<DOCNO>NCT00585481</DOCNO>
	<brief_summary>The primary objective study determine incidence severe RSV LRTI require hospitalization among infant bear &lt; 35 week gestational age one year follow-up .</brief_summary>
	<brief_title>Incidence Severe Respiratory Syncytial Virus Infections Preterm Brazilian Children</brief_title>
	<detailed_description>This epidemiologic study incidence severe RSV LRTI among Brazilian child bear &lt; 35WGA . The study enroll competitively 350 subject 3 site Brazil . Preterm child identify birth 72 hour hospital discharge follow one year enrollment . Subjects see monthly first 6 month bimonthly one year follow-up . At visit , medical social history updated physical examination perform . Legal representative notify study personnel event respiratory illness hospital admission time subject see investigator . Children LRTI diagnose physical examination viral diagnostic test perform . Subjects LRTI require hospitalization follow telephone weekly illness resolution . Hospitalized child LRTI follow daily hospitalize follow telephone illness resolution . All medical intervention outcomes record .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>Male female infant bear &lt; 35 week gestational age The inclusion must do follow period : 24 hour prior confirm maternity hospital discharge date , Up 72 hour document maternity hospital discharge date . In case , RSV rapid test must perform subject enrol result negative . Less 6 month age screen Born transfer participate hospital Able receive followup medical care participate site provide information followup period The legal representative capable understand comply parameter outline protocol able willing participate study , sign informed consent approve Independent Ethics Committee ( IEC ) /Institutional Review Board ( IRB ) , aspect study might relevant his/her decision participate explain his/her question doubt elucidate , prior initiation screen studyspecific procedure . RSV infection prior inclusion . Receipt palivizumab immunoglobulin preparation contain RSV specific antibody ( i.e . RSV hyperimmunoglobulin , polyclonal intravenous immunoglobulin , cytomegalovirus hyperimmunoglobulin , varicellazoster hyperimmunoglobulin )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Weeks</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Epidemiological Study</keyword>
	<keyword>Incidence severe Respiratory Syncytial Virus</keyword>
	<keyword>Preterm Brazilian child</keyword>
</DOC>